PT 141 Peptide: Australian Research Guide
PT-141 is the investigational name for bremelanotide, a synthetic cyclic melanocortin-receptor agonist studied in preclinical and clinical research. No approved therapeutic product containing it is listed on the Australian Register of Therapeutic Goods (ARTG), so an overseas approval doesn't establish Australian approval or authorise local supply.